Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alexander A. Osmolovskiy has a total of 106 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Patented Fibrinolytic Enzymes: An Overview

    by Yuan Cao, Mingxuan Gou, Abu Zar, Anna Shestakova, Alexander Osmolovskiy

    Fibrinolytic enzymes have garnered significant attention from researchers due to their immense potential in the medical field. As research continues to advance, the outcomes have become increasingly fruitful. The generation of applicable knowledge is usually accompanied by its protection through patent applications. This article compiles all patents related to "fibrinolytic enzyme" from Google Patents and the European Patent Office's Espacenet database, analyzing their core information, including publication year, application country, patent status, source of the fibrinolytic enzyme, and its various biochemical features. By combining relevant patent protection with current literature research, this article provides a novel and forward-looking summary of the current research status in the field of fibrinolytic enzymes.

  • Open Access

    Potentiated Activity of Amphotericin B-Loaded PLGA Nanoparticles Against Aspergillus fumigatus

    by Anastasia Orekhova, Andrey V. Sybachin, Veronika Lyamina, Dana Mamiy, Alexander Osmolovskiy, Oxana M. Drapkina

    Amphotericin B (AmB) is a broad-spectrum antifungal agent and a long-standing standard of care; however, its clinical use is compromised by poor solubility, off-target tissue distribution and severe dose-limiting toxicity. AmB-loaded poly (D, L-lactide-co-glycolide) nanoparticles (PLGA-AmB-NPs) were developed and characterized with respect to their physicochemical properties, antifungal activity against A. fumigatus biofilms, in vivo efficacy in the Galleria mellonella infection model, and hemolytic toxicity in vitro. Blank PLGA nanoparticles (PLGA-NPs) and PLGA-AmB-NPs exhibited mean diameters of 165 nm (PDI 0.075) and 120 nm (PDI 0.210), respectively, with negative zeta potential values consistent with colloidal stability in aqueous media. PLGA-AmB-NPs showed significantly enhanced activity against 24 h A. fumigatus biofilms compared with free AmB at concentrations of 5 and 10 µg/mL, while unloaded PLGA-NPs were inactive. Infected G. mellonella larvae treated with PLGA-AmB-NPs displayed markedly improved survival over a 5-day period relative to those receiving equivalent doses of free AmB. Furthermore, PLGA-AmB-NPs induced substantially lower hemolysis of human red blood cells than free AmB across all tested concentrations (5–20 µg/mL). PLGA-AmB-NPs represent a promising polymeric platform for the treatment of A. fumigatus infections.

  • Open Access

    Potentiated Activity of Amphotericin B-Loaded PLGA Nanoparticles Against Aspergillus fumigatus

    by Anastasia Orekhova, Andrey V. Sybachin, Veronika Lyamina, Dana Mamiy, Alexander Osmolovskiy, Oxana M. Drapkina

    Amphotericin B (AmB) is a broad‑spectrum antifungal agent and a long‑standing standard of care; however, its clinical use is compromised by poor solubility, off‑target tissue distribution and severe dose‑limiting toxicity. AmB‑loaded poly (D, L‑lactide‑co‑glycolide) nanoparticles (PLGA‑AmB‑NPs) were developed and characterised with respect to their physicochemical properties, antifungal activity against A. fumigatus biofilms, in vivo efficacy in the Galleria mellonella infection model, and hemolytic toxicity in vitro. Blank PLGA nanoparticles (PLGA‑NPs) and PLGA‑AmB‑NPs exhibited mean diameters of 165 nm (PDI 0.075) and 120 nm (PDI 0.210), respectively, with negative zeta‑potential values consistent with colloidal stability in aqueous media. PLGA‑AmB‑NPs showed significantly enhanced activity against 24 h A. fumigatus biofilms compared with free AmB at concentrations of 5 and 10 µg/mL, while unloaded PLGA‑NPs were inactive. Infected G. mellonella larvae treated with PLGA‑AmB‑NPs displayed markedly improved survival over a 5‑day period relative to those receiving equivalent doses of free AmB. Furthermore, PLGA‑AmB‑NPs induced substantially lower hemolysis of human red blood cells than free AmB across all tested concentrations (5–20 µg/mL). PLGA‑AmB‑NPs represent a promising polymeric platform for the treatment of A. fumigatus infections.

  • Open Access

    Optimization of precipitation of extracellular proteases from cultural liquid of mucoromycete Absidia spinosa

    by Y. Cao, A. A. Osmolovsky, V. G. Kreyer, V. N. Lavrenova, Ю. Цао, А. А. Осмоловский, В. Г. Крейер, В. Н. Лавренова

    Extracellular proteases of microorganisms play different physiological roles and cleave a broad range of substrates thus they are widely used in various industries. To date only a little is known about mucoromycetes as a source of proteases. The aim of this study was to investigate the proteolytic activities exhibited by extracellular enzymes of recently described producer Absidia spinosa 2337. The cultural liquid of the micromycete obtained after cultivation under previously selected optimal conditions demonstrated high total proteolytic activity as well as plasmin-like and urokinase-like activities exceeding or comparable to those of the cultural liquds of known fibrinolytic producers from the genus Aspergillus . The enzyme preparation was isolated from the cultural liquid using ammonium sulfate precipitation. To achieve the highest level of proteases precipitation 90-100% saturation of solution with ammonium sulfate was reached, while lower concentrations of salt are used to precipitate proteases from other micromycetes. After removal of ammonium sulfate more than nine proteins with gelatinase activity with molecular weights ranging from 15 to 135 kDa and higher were detected in the enzyme preparations. Further study of the unique properties of Absidia spinosa proteases may lead to the development of new thrombolytic and collagenolytic substances for biotechnology and medicine.

  • Open Access

    Production of glutenolytic proteases by the micromycete Aspergillus parasiticus

    by V. M. Liamina, A. K. Akyol, E. I. Kornienko, V. G. Kreyer, A. A. Osmolovskiy, В. М. Лямина, А. К. Акьол, Е. И. Корниенко, В. Г. Крейер, А. А. Осмоловский

    Gluten-related disorders are among the most common nutritional disorders in humans. Due to the demand for glutenase enzyme preparations, a previously unstudied, but specifically gluten-hydrolyzing protease was isolated and purified from the culture fluid of the micromycete Aspergillus parasiticus . This protease has a molecular weight of approximately 30 kDa and a isoelectric point of 4,8. The enzyme also exhibits high proteolytic activity toward fibrinogen and low activity toward bovine serum albumin. The purity of the isolated protease was confirmed electrophoretically.

  • Proteolytic Profiles of Aspergillus caespitosus, A. jensenii and A. neotritici,and a Novel Peptidase with Plasmin-like Activity for Biomedicine andPharmacology

    by Sergey Klyagin, Irina Maklakova, Nina Tomic, Anna Shestakova, Elena Pieckova, Alexander Osmolovskiy

    Introduction: Cardiovascular diseases (CVDs) are the leading cause of death globally, often complicated by thromboembolic events. Plasmin, a key enzyme in fibrinolysis, is crucial for managing these conditions. Elevated or reduced plasmin levels can indicate thrombotic risks, making it a valuable diagnostic marker. Recent biotechnological advances have developed diagnostic kits to measure plasmin activity, aiding early detection and intervention. Fungal proteases, particularly from micromycetes, are emerging as promising agents in anticoagulant therapy. This study investigates three Aspergillus species — A. caespitosus, A. jensenii and A.neotritici — for their potential to produce novel biomedical components. Methods: The fungi were cultured, and their proteolytic profiles were analyzed. Key findings include the identification of specific proteases with plasmin-like and protein C-activating activities. These enzymes were purified using isoelectric focusing and characterized through SDSPAGE and zymography. Results: The study confirmed that A. jensenii, and A. neotritici produce proteases with plasminlike activity, with A. neotritici showing a single 35 kDa non-specific protease, and A. jensenii exhibiting two proteases (33 kDa and 100 kDa) in the acidic zone and one (110 kDa) in the neutral zone, the latter exhibiting specific chymotrypsin and plasmin-like activity. Discussion: Among the studied strains, A. neotritici exhibited the fastest secretion of proteases with plasmin-like activity, making it a promising source of enzymes with potential clinical applications. In contrast, A. caespitosus and A. jensenii displayed more complex protease compositions, featuring multiple active enzymes. Notably, one of the A. jensenii proteases showed pronounced specificity toward chymotrypsin and fibrinolytic substrates, indicating its suitability for the development of targeted therapeutic agents. result: The study identified proteases from A. caespitosus, A. jensenii, and A. neotritici. A. neotritici produced a single, 35 kDa non-specific protease, and A. caespitosus produced three (180 kDa, 140 kDa, and 65 kDa). A. jensenii displayed two proteases (33 kDa and 100 kDa) in the acidic zone and a 110 kDa protease in the neutral zone, with the latter exhibiting specific chymotrypsin and plasmin-like activity. Conclusion: These findings suggest the potential of these fungal proteases for developing novel anticoagulant therapies and diagnostic tools.

  • Open Access

    FIBRINOLYTIC PROTEASES OF ENTOMOPATHOGENIC MICROMYCETES: PRODUCTION AND CHARACTERISTICS

    by Daria L. Basalaeva, Anna A. Bogomolova, Alexander A. Osmolovskiy

    The search for new fibrinolytic enzymes is of great interest, as they are widely used in the treatment of thromboembolic conditions. However, existing treatments are limited and may cause side effects. The aim of the study is to find out whether entomopathogenic micromycetes can produce fibrinolytic enzymes and to study their properties. Primary screening of proteolytic enzyme production was performed among 15 strains of entomopathogenic micromycetes. After cultivation of the producer strain and precipitation with ammonium sulfate, followed by purification by dialysis, enzyme extracts were obtained. Fractionation was then performed using isoelectric focusing to isolate individual samples for the analysis of the proteolytic activity of fungal strains. Three most promising strains from the Cordycipitaceae and Ophiocordycipitaceae families were selected. The most suitable cultivation conditions were determined, and the producing strain was selected. Micromycetes have demonstrated a significant ability to break down protein molecules. Consequently, a comprehensive analysis of proteolytic activity was conducted in 15 entomopathogenic strains. The dynamics of protease accumulation in the nutrient medium was investigated in three strains after submerged cultivation. A preparation of a proteolytic enzyme from the micromycete Akanthomyces cf. aculeatus, exhibiting both overall proteolytic and fibrinolytic activities, was obtained. The results indicate that the proteolytic agent under consideration is a protein with a molecular weight estimated at approximately 35 kDa and an isoelectric point of 2.15. Moreover, it has been confirmed that this enzyme can cleave both fibrin and fibrinogen according to SDS-PAGE analysis.


  • Screening of New Producers of Proteolytic Enzymes among Micromycetes of Mucoromycota

    by Yuan Cao, Alina V. Alexandrova, Elena Piecková, Alexander A. Osmolovskiy

    Yuan Cao, Alina V. Alexandrova, Elena Piecková, and Alexander A. Osmolovskiy. Microbiol. Biotechnol. Lett. 2025;53:48-56. https://doi.org/10.48022/mbl.2409.09001

  • Open Access

    First Insight into the Degradome of Aspergillus ochraceus: Novel Secreted Peptidases and Their Inhibitors

    by Anna Shestakova, Artem Fatkulin, Daria Surkova, Alexander Osmolovskiy, Elizaveta Popova

    Aspergillus fungi constitute a pivotal element within ecosystems, serving as both contributors of biologically active compounds and harboring the potential to cause various diseases across living organisms. The organism’s proteolytic enzyme complex, termed the degradome, acts as an intermediary in its dynamic interaction with the surrounding environment. Using techniques such as genome and transcriptome sequencing, alongside protein prediction methodologies, we identified putative extracellular peptidases within Aspergillus ochraceus VKM-F4104D. Following manual annotation procedures, a total of 11 aspartic, 2 cysteine, 2 glutamic, 21 serine, 1 threonine, and 21 metallopeptidases were attributed to the extracellular degradome of A. ochraceus VKM-F4104D. Among them are enzymes with promising applications in biotechnology, potential targets and agents for antifungal therapy, and microbial antagonism factors. Thus, additional functionalities of the extracellular degradome, extending beyond mere protein substrate digestion for nutritional purposes, were demonstrated.


  • Open Access

    KERATINOLYTIC POTENTIAL OF MICROMYCETE ASPERGILLUS CLAVATUS VKPM F-1593 AND COMPARISON OF ITS ENZYMES WITH THE COMMERCIAL KERATINASE PREPARATION

    by S.N. Timorshina, Е. А. Попова, K.I. Kuleshova, А. К. Акьол, А. А. Осмоловский

    Animal husbandry is a rapidly developing branch of agriculture, increasing the volume of production annually, and keratin-containing waste (feathers, bristles) make up the majority of all waste from this industry. The development of methods of environmentally friendly processing of such waste to obtain valuable resources (amino acids and oligopeptides) is an important mission of modern science, including biotechnology. One of the ways to dispose of animal husbandry waste that meets modern trends in the development of a green economy is the use of microorganisms and their enzymes. The possibility of obtaining keratinolytic enzymes of Aspergillus clavatus VKPM F-1593 under deep conditions with various sources of nitrogen and carbon, including with the growth of the producer on animal waste, was studied. The highest target activity (96.1 E) was achieved using mixed carbon and nitrogen sources: inorganic - sodium nitrate, easily digestible organic - fi sh meal hydrolysate and hard-toreach organic - ground chicken feather. Varying the content of various substrates in the composition of fermentation media allowed not only to regulate the level of proteolytic activity, but also to reach the peak of producer activity on diff erent days of cultivation. The specifi c keratinase activity of A. clavatus VKPM F-1593 (pI 9.3) to various protein substrates with the activity of a commercial proteinase K. Both enzymes showed a similar level of activity regarding most of the substrates used. However, protease A. clavatus VKPM F-1593 has a greater overall proteolytic activity, which confi rms the prospects of this culture for biodegradation of animal waste